Cambridge Biotherapies Introduces Ketamine Infusions for Opioid-Free Pain Relief

BEVERLY, Mass., May 22, 2024—Cambridge Biotherapies™, a prominent mental health treatment provider in Massachusetts, is excited to announce the introduction of Ketamine Infusions for Pain and Headache Management across all its locations. This addition reaffirms the organization's dedication to offering pioneering treatments aimed at significantly enhancing the quality of life for individuals suffering from chronic pain and migraine headaches.

The new service places Cambridge Biotherapies at the forefront of innovative pain management solutions, giving patients access to a treatment method that has demonstrated effectiveness in mitigating chronic pain and migraines. As one of the fastest-growing psychiatrist-led facilities offering ketamine infusion treatments in Boston and its surrounding areas, Cambridge Biotherapies delivers a unique, comprehensive experience within a warm and welcoming environment.

Massachusetts is currently grappling with a worsening mental health crisis, as more residents seek effective treatments for mental health and chronic pain issues. By expanding its services to all locations in Amherst, Beverly, and Cambridge, Cambridge Biotherapies aims to meet the increasing demand for all-encompassing mental health care. The introduction of Ketamine Infusions for Pain and Headache Management responds directly to the need for innovative and effective treatment options in the region.

Ketamine for pain management presents an emerging treatment alternative, offering a viable substitute to opioids, particularly amidst the ongoing opioid crisis. This controlled method of pain management provides patients with a promising option that has shown success where traditional treatments have not. The launch of this service exemplifies Cambridge Biotherapies' commitment to consistently delivering advanced treatment options that can enhance patients' quality of life.

Recent studies have highlighted the significant effectiveness of Ketamine Infusions in reducing pain for patients with various chronic pain conditions. For instance, research published in the Journal of Pain Research revealed that 75% of patients with Complex Regional Pain Syndrome (CRPS) experienced substantial pain relief following Ketamine Infusions. Additionally, studies indicate a decrease in overall opioid usage compared to control groups, underlining ketamine's potential as a safer pain management option.

Dr. Daniel Brenner, the Founder and Medical Director of Cambridge Biotherapies, stated, "At Cambridge Biotherapies, we are dedicated to transforming mental health and pain management by offering the most innovative and effective treatments available. Our new Ketamine Infusions for Pain Management provide hope and relief for patients who have struggled with chronic pain, giving them a new lease on life."

With over 50 million Americans seeking mental health treatment annually, the inclusion of Ketamine Infusions for Pain Management offers a crucial service that addresses both mental health and chronic pain. This holistic care integrates support for both mental and physical health, ensuring comprehensive treatment for those in need.

Cambridge Biotherapies™ is a leading private mental health treatment facility committed to revolutionizing mental health care. Under the leadership of Harvard-trained Psychiatrist and Chief Medical Officer, Dr. Daniel Brenner, their multi-specialty team specializes in groundbreaking treatments such as Accelerated Transcranial Magnetic Stimulation (TMS), Ketamine Infusion Therapy, and Psychedelic Therapy, along with traditional Medication Management and Psychotherapy. With three locations and recognition as one of Massachusetts's fastest-growing mental health providers, Cambridge Biotherapies remains dedicated to offering cutting-edge treatments and transforming lives.